메뉴 건너뛰기




Volumn 117, Issue 6, 2017, Pages 1164-1170

External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism

Author keywords

Anticoagulation; Bleeding; Clinical prediction rule; Deep vein thrombosis; Edoxaban; Pulmonary embolism; Warfarin

Indexed keywords

EDOXABAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT; PYRIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

EID: 85020263983     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH16-10-0810     Document Type: Article
Times cited : (65)

References (14)
  • 1
    • 84949624113 scopus 로고    scopus 로고
    • Recent developments in the diagnosis and treatment of pulmonary embolism
    • van der Hulle T, Dronkers CE, Klok FA, Huisman MV. Recent developments in the diagnosis and treatment of pulmonary embolism. J Intern Med 2016; 279:16-29.
    • (2016) J Intern Med , vol.279 , pp. 16-29
    • van der Hulle, T.1    Dronkers, C.E.2    Klok, F.A.3    Huisman, M.V.4
  • 2
    • 84911864852 scopus 로고    scopus 로고
    • 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS)
    • Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014; 35: 3033-3069.
    • (2014) Eur Heart J , vol.35 , pp. 3033-3069
    • Konstantinides, S.V.1    Torbicki, A.2    Agnelli, G.3
  • 3
    • 84958038787 scopus 로고    scopus 로고
    • Antithrombotic Therapy for VTE Disease:CHEST Guideline and Expert Panel Report
    • Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease:CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315-352.
    • (2016) Chest , vol.149 , pp. 315-352
    • Kearon, C.1    Akl, E.A.2    Ornelas, J.3
  • 4
    • 84916931597 scopus 로고    scopus 로고
    • Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study
    • Riva N, Bellesini M, Di Minno MN, et al. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study. Thromb Haemost 2014; 112: 511-521.
    • (2014) Thromb Haemost , vol.112 , pp. 511-521
    • Riva, N.1    Bellesini, M.2    Di Minno, M.N.3
  • 5
    • 84956886760 scopus 로고    scopus 로고
    • Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism
    • Klok FA, Niemann C, Dellas C, et al. Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism. J Thromb Thrombolysis 2016; 41: 312-320.
    • (2016) J Thromb Thrombolysis , vol.41 , pp. 312-320
    • Klok, F.A.1    Niemann, C.2    Dellas, C.3
  • 6
    • 84920599855 scopus 로고    scopus 로고
    • Predicting anticoagulant-related bleeding in patients with venous thromboembolism: A clinically oriented review
    • Klok FA, Kooiman J, Huisman MV, et al. Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review. Eur Respir J 2014; 45: 201-210.
    • (2014) Eur Respir J , vol.45 , pp. 201-210
    • Klok, F.A.1    Kooiman, J.2    Huisman, M.V.3
  • 7
    • 84994338117 scopus 로고    scopus 로고
    • Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
    • Klok FA, Hosel V, Clemens A, et al. Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment. Eur Respir J 2016; 48: 1369-1376.
    • (2016) Eur Respir J , vol.48 , pp. 1369-1376
    • Klok, F.A.1    Hosel, V.2    Clemens, A.3
  • 8
    • 71849117615 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in the treatment of acute venous thromboembolism
    • Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009; 361:2342-2352.
    • (2009) N Engl J Med , vol.361 , pp. 2342-2352
    • Schulman, S.1    Kearon, C.2    Kakkar, A.K.3
  • 9
    • 84894295323 scopus 로고    scopus 로고
    • Treatment of Acute Venous Thromboembolism with Dabigatran or Warfarin and Pooled Analysis
    • Schulman S, Kakkar AK, Goldhaber SZ, et al. Treatment of Acute Venous Thromboembolism with Dabigatran or Warfarin and Pooled Analysis. Circulation 2014; 129: 764-772.
    • (2014) Circulation , vol.129 , pp. 764-772
    • Schulman, S.1    Kakkar, A.K.2    Goldhaber, S.Z.3
  • 10
    • 84885618705 scopus 로고    scopus 로고
    • Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism
    • Buller HR, Decousus H, Grosso MA, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013; 369:1406-1415.
    • (2013) N Engl J Med , vol.369 , pp. 1406-1415
    • Buller, H.R.1    Decousus, H.2    Grosso, M.A.3
  • 11
    • 84880397241 scopus 로고    scopus 로고
    • Edoxaban for the long-term treatment of venous thromboembolism: Rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials
    • Raskob G, Buller H, Prins M, et al. Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials. J Thromb Haemost 2013; 11: 1287-1294.
    • (2013) J Thromb Haemost , vol.11 , pp. 1287-1294
    • Raskob, G.1    Buller, H.2    Prins, M.3
  • 12
    • 23044505564 scopus 로고    scopus 로고
    • Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
    • Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694.
    • (2005) J Thromb Haemost , vol.3 , pp. 692-694
    • Schulman, S.1    Kearon, C.2
  • 13
    • 82655181075 scopus 로고    scopus 로고
    • Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer New York
    • Steyerberg EW. Overfitting and optimism in prediction models. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer New York, 2009: pp. 83-100.
    • (2009) Overfitting and optimism in prediction models , pp. 83-100
    • Steyerberg, E.W.1
  • 14
    • 79952582388 scopus 로고    scopus 로고
    • Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY:Springer New York
    • Steyerberg EW. Validation of Prediction Models. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY:Springer New York, 2009: pp. 299-311.
    • (2009) Validation of Prediction Models , pp. 299-311
    • Steyerberg, E.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.